2017
DOI: 10.1002/jcb.26299
|View full text |Cite
|
Sign up to set email alerts
|

1‐palmitoyl‐2‐linoleoyl‐3‐acetyl‐rac‐glycerol (PLAG) reduces hepatic injury in concanavalin A‐treated mice

Abstract: 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG), a chemically synthesized monoacetyldiaglyceride, is one of the constituents in Sika deer antlers and has been known traditionally as having immunomodulatory effects. However, the mechanism by which PLAG controls neutrophil migration, which evokes liver injury in the hepatitis animal model, remains largely unknown. This study was designed to evaluate the immunomodulatory effects of PLAG on cytokine secretion and neutrophil migration in vivo and in vitro. Con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 54 publications
0
12
0
Order By: Relevance
“…As reported elsewhere, it has been shown that PLAG is an effective therapeutic candidate in different inflammatoryassociated diseases, such as rheumatoid arthritis, atopic dermatitis, asthma and hepatitis (20,(34)(35)(36). In addition, the therapeutic efficacy of PLAG has been demonstrated in chemotherapy and radiation-induced oral mucositis in hamster and mouse models, through the effective attenuation of neutrophil infiltration into cheek pouches and tongues and a decrease in inflammatory cytokines (37).…”
Section: Discussionmentioning
confidence: 73%
“…As reported elsewhere, it has been shown that PLAG is an effective therapeutic candidate in different inflammatoryassociated diseases, such as rheumatoid arthritis, atopic dermatitis, asthma and hepatitis (20,(34)(35)(36). In addition, the therapeutic efficacy of PLAG has been demonstrated in chemotherapy and radiation-induced oral mucositis in hamster and mouse models, through the effective attenuation of neutrophil infiltration into cheek pouches and tongues and a decrease in inflammatory cytokines (37).…”
Section: Discussionmentioning
confidence: 73%
“…The precise mechanistic relevance of these observations are not clear at present and remain the subject of ongoing research in our group. However, a potential explanation is that the anti-inflammatory response may be liver centric and attempting to reduce the extent of parenchymal injury whilst the increase in inflammatory markers is allowing the potential influx of immune cells that are required for later liver injury resolution ( 60 , 61 ).…”
Section: Discussionmentioning
confidence: 99%
“…Activation of the NACHT, LRR, and PYD domains-containing protein3 inflammasome leading to interleukin-1β (IL-1β) release is a putative pathogenesis of acute gouty inflammation triggered by MSU crystals (8,9). High concentration of CXC motif chemokine ligand 8 (CXCL8/IL-8) occurs in the synovial fluid of acute gout patients (10).…”
Section: Introductionmentioning
confidence: 99%
“…PLAG reduces lipopolysaccharideinduced macrophage inflammatory protein 2 (MIP-2) and CXCL8 secretion (29). PLAG improves hepatic injury in concanavalin A-treated mice (9), and gemcitabine-induced neutropenia (30,31) and oral mucositis in hamster and mouse models (32), via modulation of neutrophil migration. In this study, the mitigating effects of PLAG in MSU-induced acute gouty inflammation through modulation of neutrophil infiltration were investigated.…”
Section: Introductionmentioning
confidence: 99%